Jun 7, 2003|
Global markets: Will the rally continue?
Globally, the markets were in positive territory during the week. In US, indices reached their highest levels for the year. Both the Dow and the NASDAQ gained about 2% in the entire week. This was on account of rising investor optimism regarding recovery in the US economy during the second half of the current fiscal. The week started on a positive note from the economic standpoint. Manufacturing reports, which were better than expected fueled optimism early on. Also, success of several cancer drugs raised the stocks in the drugs sector.
The next two days saw the US indices surging further. This was on account of positive reports from the services sector (the service index improved to 54 from its April figures of 50). This led to gains in technology stocks. However investigations against IBM from Securities Exchange Commission pared the gains. Dow touched its 9,000 levels during this session.
On Thursday and Friday, US markets remained mixed, however the underlying sentiment was bullish. Despite poor unemployment numbers for the last week of May, market sentiments were not hampered and the indices continued to move higher. This apart, better than expected job reports for the month of May raised further optimism. However some profit booking was seen towards the end of closing this week. Despite this, the Indices managed to close higher for the week. Next week will see further economic reports and this will further drive investor sentiments.
Globally indices continued to trade strong for the second consecutive week. This week the top gainers were Dax (5%), Nikkei (4%) and BSE (4%). Overall investor optimism seems to be positive. With the expectation that US economic recovery may happen in the second half of the current fiscal, exports in both Asia and Europe, which are dependent on US markets, may receive a boost and this is leading to optimism in other markets worldwide. This apart, the effect of SARS is also fading away.
|(Price in US $)
Indian ADRs remained strong for the week barring some weakness in Rediff (9%). Silverline Technologies was the top gainer and it was up 65%. Technology ADRs were among the major gainers during the week. However one needs to be cautious on this front considering the declining margins and weak global IT spending. Dr. Reddy's Laboratories was one of the major gainers for the week. The company had announced its FY03 results last week and it expects the growth in its US business to be at higher levels going forward. The stock is trading near its 52-week highs.
Last two weeks has seen the global indices moving up and there has been an increase in investor optimism world over. This is seen from the fact that the NASDAQ has gained about 24% in this year. From here on it would be interesting to see if the rally is likely to be sustained since there are no clear long term signs of recovery in the US economy. Hence one must exercise caution instead of going overboard.
More Views on News
Jun 10, 2017
Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.
Aug 19, 2017
Ever heard of Lindy Effect? Find out how you can use it to pick timeless stocks.
Aug 18, 2017
Buying the index now will hardly help make money in stocks even in ten years.
Aug 18, 2017
Donald J Trump, a wrasslin' fan, took a 'Holy Sh*t!' blow on Tuesday.
Aug 17, 2017
PersonalFN simplifies the mutual fund account statement for you.
More Views on News
Aug 7, 2017
The data tells us quite a different story from the one the government is trying to project.
Aug 10, 2017
Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.
Aug 8, 2017
Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 7, 2017
Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: email@example.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407